Cargando…
Serum metabolomic profiling facilitates the non-invasive identification of metabolic biomarkers associated with the onset and progression of non-small cell lung cancer
Lung cancer (LC) is responsible for most cancer deaths. One of the main factors contributing to the lethality of this disease is the fact that a large proportion of patients are diagnosed at advanced stages when a clinical intervention is unlikely to succeed. In this study, we evaluated the potentia...
Autores principales: | Puchades-Carrasco, Leonor, Jantus-Lewintre, Eloisa, Pérez-Rambla, Clara, García-García, Francisco, Lucas, Rut, Calabuig, Silvia, Blasco, Ana, Dopazo, Joaquín, Camps, Carlos, Pineda-Lucena, Antonio |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Impact Journals LLC
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4914330/ https://www.ncbi.nlm.nih.gov/pubmed/26883203 http://dx.doi.org/10.18632/oncotarget.7354 |
Ejemplares similares
-
Non-invasive urinary metabolomic profiling discriminates prostate cancer from benign prostatic hyperplasia
por: Pérez-Rambla, Clara, et al.
Publicado: (2017) -
MicroRNAs: Promising New Antiangiogenic Targets in Cancer
por: Gallach, Sandra, et al.
Publicado: (2014) -
MicroRNA profiling associated with non-small cell lung cancer: next generation sequencing detection, experimental validation, and prognostic value
por: Gallach, Sandra, et al.
Publicado: (2017) -
Metabolomics Applications in Precision Medicine: An Oncological Perspective
por: Puchades-Carrasco, Leonor, et al.
Publicado: (2017) -
Analysis of the Gut Microbiota: An Emerging Source of Biomarkers for Immune Checkpoint Blockade Therapy in Non-Small Cell Lung Cancer
por: Zhang, Feiyu, et al.
Publicado: (2021)